Pentanet Limited (ASX:5GG)

Achilles Therapeutics Revenue

Pentanet had revenue of 11.26M AUD in the half year ending December 31, 2024, with 13.08% growth. This brings the company's revenue in the last twelve months to 21.92M, up 4.12% year-over-year. In the fiscal year ending June 30, 2024, Pentanet had annual revenue of 21.44M with 5.96% growth.

• Revenue (ttm): 21.92M
• Revenue Growth: +4.12%
• P/S Ratio: 0.51
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 11.26M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	21.44M	1.21M	5.96%
Jun 30, 2023	20.23M	3.40M	20.22%
Jun 30, 2022	16.83M	5.91M	54.15%
Jun 30, 2021	10.92M	5.92M	118.47%
Jun 30, 2020	5.00M	3.22M	181.08%